4-(2,4-二甲氧基苯基)-噻唑-2-胺结构式
|
常用名 | 4-(2,4-二甲氧基苯基)-噻唑-2-胺 | 英文名 | 4-(2,4-DIMETHOXY-PHENYL)-THIAZOL-2-YLAMINE |
|---|---|---|---|---|
| CAS号 | 23111-45-7 | 分子量 | 236.29000 | |
| 密度 | 1.258g/cm3 | 沸点 | 394.6ºC at 760mmHg | |
| 分子式 | C11H12N2O2S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 192.5ºC |
| 中文名 | 4-(2,4-二甲氧基苯基)-噻唑-2-胺 |
|---|---|
| 英文名 | 4-(2,4-dimethoxyphenyl)-1,3-thiazol-2-amine |
| 密度 | 1.258g/cm3 |
|---|---|
| 沸点 | 394.6ºC at 760mmHg |
| 分子式 | C11H12N2O2S |
| 分子量 | 236.29000 |
| 闪点 | 192.5ºC |
| 精确质量 | 236.06200 |
| PSA | 85.61000 |
| LogP | 2.99070 |
| InChIKey | NRGCDEWBJMQJBX-UHFFFAOYSA-N |
| SMILES | COc1ccc(-c2csc(N)n2)c(OC)c1 |
| 蒸汽压 | 1.95E-06mmHg at 25°C |
| 折射率 | 1.608 |
| 危害码 (欧洲) | Xi: Irritant; |
|---|---|
| 海关编码 | 2934100090 |
|
~63%
4-(2,4-二甲氧基苯基)-... 23111-45-7 |
| 文献:TAIVEX THERAPEUTICS CORPORATION; HUANG, Yu-Ling; CHUANG, Shih-Hsien; LEE, Ying-Shuan Eda; HUANG, Jiann-Jyh; LAU, Johnson Patent: WO2013/82324 A1, 2013 ; Location in patent: Paragraph 00352 ; |
|
~%
4-(2,4-二甲氧基苯基)-... 23111-45-7 |
| 文献:TAIVEX THERAPEUTICS CORPORATION; HUANG, Yu-Ling; CHUANG, Shih-Hsien; LEE, Ying-Shuan Eda; HUANG, Jiann-Jyh; LAU, Johnson Patent: WO2013/82324 A1, 2013 ; |
|
~%
4-(2,4-二甲氧基苯基)-... 23111-45-7 |
| 文献:Boucherle,A. et al. Chimica Therapeutica, 1968 , vol. 3, p. 360 - 363 |
| 4-(2,4-二甲氧基苯基)-噻唑-2-胺上游产品 3 | |
|---|---|
| 4-(2,4-二甲氧基苯基)-噻唑-2-胺下游产品 0 | |
| 海关编码 | 2934100090 |
|---|---|
| 中文概述 | 2934100090. 结构上含有一个非稠合噻唑环的化合物(不论是否氢化). 增值税率:17.0%. 退税率:9.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |
|
实验名称:Screen for inhibitors of RMI FANCM (MM2) intereaction
来源:11908
靶标:N/A
External Id:RMI-FANCM-MM2
|
|
实验名称:Alphascreen assay for small molecules abrogating mHTT-CaM Interaction
来源:24983
靶标:Huntingtin
External Id:KUHTS-Muma KU-CaM-Htt INH-01
|